Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Cereb Blood Flow Metab ; 31(2): 671-9, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20842159

ABSTRACT

Vascular risk factors affect cerebral blood flow (CBF) and cerebral vascular reactivity, contributing to cognitive decline. Hippocampus is vulnerable to both Alzheimer's disease (AD) pathology and ischemia; nonetheless, the information about the impact of vascular risk on hippocampal perfusion is minimal. Cognitively, healthy elderly (NL=18, 69.9±6.7 years) and subjects with mild cognitive impairment (MCI=15, 74.9±8.1 years) were evaluated for the Framingham cardiovascular risk profile (FCRP). All underwent structural imaging and resting CBF assessment with arterial spin labeling (ASL) at 3T magnetic resonance imaging (MRI). In 24 subjects (NL=17, MCI=7), CBF was measured after a carbon dioxide rebreathing challenge. Across all subjects, FCRP negatively correlated with hippocampal (ρ=-0.41, P=0.049) and global cortical (ρ=-0.46, P=0.02) vasoreactivity to hypercapnia (VR(h)). The FCRP-VR(h) relationships were most pronounced in the MCI group: hippocampus (ρ=-0.77, P=0.04); global cortex (ρ=-0.83, P=0.02). The FCRP did not correlate with either volume or resting CBF. The hippocampal VR(h) was lower in MCI than in NL subjects (Z=-2.0, P=0.047). This difference persisted after age and FCRP correction (F([3,20])=4.6, P=0.05). An elevated risk for vascular pathology is associated with a reduced response to hypercapnia in both hippocampal and cortical tissue. The VR(h) is more sensitive to vascular burden than either resting CBF or brain volume.


Subject(s)
Cardiovascular Diseases/epidemiology , Cerebral Cortex/pathology , Cerebrovascular Circulation/physiology , Hippocampus/pathology , Hypercapnia/pathology , Aged , Aged, 80 and over , Algorithms , Atrophy , Calibration , Carbon Dioxide/blood , Carbon Dioxide/pharmacology , Female , Humans , Hypercapnia/physiopathology , Image Processing, Computer-Assisted , Infarction, Middle Cerebral Artery/epidemiology , Infarction, Middle Cerebral Artery/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Neuropsychological Tests , Perfusion Imaging , Risk Assessment
2.
Magn Reson Med ; 65(1): 128-37, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20939094

ABSTRACT

Due to methodological difficulties related to the small size, variable distribution of hippocampal arteries, and the location of the hippocampus in the proximity of middle cranial fossa, little is known about hippocampal blood flow (HBF). We have tested the utility of a pulsed arterial spin labeling sequence based on multi-shot true fast imaging in steady precession to measure HBF in 34 normal volunteers (17 women, 17 men, 26-92 years old). Flow sensitivity to a mild hypercapnic challenge was also examined. Coregistered 3D MPRAGE sequence was used to eliminate from hippocampal and cortical regions of interest all voxel with <75% of gray matter. Large blood vessels were also excluded. HBF in normal volunteers averaged 61.2 ± 9.0 mL/(100 g min). There was no statistically significant age or gender effect. Under a mild hypercapnia challenge (end tidal CO(2) pressure increase of 6.8 ± 1.9 mmHg over the baseline), HBF response was 14.1 ± 10.8 mL/(100 g min), whereas cortical gray matter flow increased by 18.0 ± 12.2 mL/(100 g min). Flow response among women was significantly larger than in the men. The average absolute difference between two successive HBF measures was 3.6 mL/(100 g min) or 5.4%. The 3T true fast imaging in steady precession arterial spin labeling method offers a HBF measurement strategy that combines good spatial resolution, sensitivity, and minimal image distortions.


Subject(s)
Aging/physiology , Cerebral Arteries/physiology , Hippocampus/physiology , Magnetic Resonance Angiography/methods , Adult , Aged , Aged, 80 and over , Aging/pathology , Blood Flow Velocity/physiology , Cerebral Arteries/anatomy & histology , Female , Hippocampus/blood supply , Humans , Male , Middle Aged , Spin Labels
3.
J Alzheimers Dis ; 18(3): 509-13, 2009.
Article in English | MEDLINE | ID: mdl-19661628

ABSTRACT

Previous studies showed that memantine inhibits tau hyperphosphorylation in vitro. In this study, phosphorylated tau (P-tau) and total tau (T-tau) were measured before and after 6 month treatment with memantine in 12 subjects ranging from normal cognition with subjective memory complaints, through mild cognitive impairment to mild Alzheimer's disease. Thirteen non-treated individuals served as controls. Treatment was associated with a reduction of P-tau in subjects with normal cognition. No treatment effects were seen among impaired individuals, suggesting that longer treatment time may be necessary to achieve biomarker effect in this group.


Subject(s)
Alzheimer Disease , Antiparkinson Agents/pharmacology , Antiparkinson Agents/therapeutic use , Brain/pathology , Memantine/pharmacology , Memantine/therapeutic use , Neurofibrillary Tangles/pathology , Aged , Alzheimer Disease/cerebrospinal fluid , Alzheimer Disease/drug therapy , Alzheimer Disease/pathology , Biomarkers/cerebrospinal fluid , Cognition Disorders/diagnosis , Cognition Disorders/drug therapy , Cognition Disorders/pathology , Female , Humans , Male , Neuropsychological Tests , Phosphorylation/drug effects , Severity of Illness Index , Spinal Puncture , tau Proteins/metabolism
4.
J Alzheimers Dis ; 16(2): 351-62, 2009.
Article in English | MEDLINE | ID: mdl-19221425

ABSTRACT

Little is known of combined utility of magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) biomarkers for prediction of Alzheimer's disease (AD) and longitudinal data is scarce. We examined these biomarkers at baseline and longitudinally in incipient AD. Forty-five subjects [21 controls (NL-NL), 16 stable MCI (MCI-MCI), 8 MCI who declined to AD (MCI-AD)] received MRI and lumbar puncture at baseline and after 2 years. CSF measures included total and phosphorylated tau (T-tau, P-tau(231)), amyloid-beta (Abeta(42)/Abeta(40)) and isoprostane. Voxel-based morphometry identified gray matter concentration (GMC) differences best distinguishing study groups and individual GMC values were calculated. Rate of medial temporal lobe (MTL) atrophy was examined using regional boundary shift (rBS) method. At baseline, for MRI, MCI-AD showed reduced GMC-MTL, and for CSF higher CSF T-tau, P-tau(231), IP and lower Abeta(42)/Abeta(40) as compared with MCI-MCI or NL-NL. Longitudinally, rBS-MTL atrophy was higher in MCI-AD than in either MCI-MCI or NL-NL, particularly in the left hemisphere. CSF data showed longitudinally greater increases of isoprostane in MCI-AD as compared with NL-NL. Combining baseline CSF-P-tau(231) and GMC-MTL significantly increased overall prediction of AD from 74% to 84% (p(step)<0.05). These results provide support for including multiple modalities of biomarkers in the identification of memory clinic patients at increased risk for dementia.


Subject(s)
Alzheimer Disease/cerebrospinal fluid , Alzheimer Disease/pathology , Magnetic Resonance Imaging/methods , Aged , Alzheimer Disease/complications , Alzheimer Disease/genetics , Amyloid beta-Peptides/cerebrospinal fluid , Apolipoprotein E4/genetics , Area Under Curve , Cognition Disorders/cerebrospinal fluid , Cognition Disorders/complications , Cognition Disorders/diagnosis , Cognition Disorders/genetics , Female , Functional Laterality , Gas Chromatography-Mass Spectrometry , Humans , Image Processing, Computer-Assisted , Isoprostanes/cerebrospinal fluid , Longitudinal Studies , Male , Middle Aged , Peptide Fragments/cerebrospinal fluid , Sensitivity and Specificity , tau Proteins/cerebrospinal fluid
5.
Eur J Nucl Med Mol Imaging ; 36(5): 811-22, 2009 May.
Article in English | MEDLINE | ID: mdl-19142633

ABSTRACT

PURPOSE: We report the first clinicopathological series of longitudinal FDG-PET scans in post-mortem (PM) verified cognitively normal elderly (NL) followed to the onset of Alzheimer's-type dementia (DAT), and in patients with mild DAT with progressive cognitive deterioration. METHODS: Four NL subjects and three patients with mild DAT received longitudinal clinical, neuropsychological and dynamic FDG-PET examinations with arterial input functions. NL subjects were followed for 13 +/- 5 years, received FDG-PET examinations over 7 +/- 2 years, and autopsy 6 +/- 3 years after the last FDG-PET. Two NL declined to mild cognitive impairment (MCI), and two developed probable DAT before death. DAT patients were followed for 9 +/- 3 years, received FDG-PET examinations over 3 +/- 2 years, and autopsy 7 +/- 1 years after the last FDG-PET. Two DAT patients progressed to moderate-to-severe dementia and one developed vascular dementia. RESULTS: The two NL subjects who declined to DAT received a PM diagnosis of definite AD. Their FDG-PET scans indicated a progression of deficits in the cerebral metabolic rate for glucose (CMRglc) from the hippocampus to the parietotemporal and posterior cingulate cortices. One DAT patient showed AD with diffuse Lewy body disease (LBD) at PM, and her last in vivo PET was indicative of possible LBD for the presence of occipital as well as parietotemporal hypometabolism. CONCLUSION: Progressive CMRglc reductions on FDG-PET occur years in advance of clinical DAT symptoms in patients with pathologically verified disease. The FDG-PET profiles in life were consistent with the PM diagnosis.


Subject(s)
Alzheimer Disease/diagnostic imaging , Alzheimer Disease/diagnosis , Brain/metabolism , Fluorodeoxyglucose F18/pharmacology , Glucose/metabolism , Positron-Emission Tomography/methods , Aged , Aged, 80 and over , Autopsy , Cognition Disorders/diagnosis , Cognition Disorders/diagnostic imaging , Dementia, Vascular/diagnosis , Dementia, Vascular/diagnostic imaging , Female , Hippocampus/metabolism , Humans , Lewy Body Disease/metabolism , Male
6.
Neurobiol Aging ; 30(5): 682-90, 2009 May.
Article in English | MEDLINE | ID: mdl-17889968

ABSTRACT

OBJECTIVES: To longitudinally evaluate five cerebrospinal fluid (CSF) biomarkers in the transition from mild cognitive impairment (MCI) to Alzheimer's disease (AD). METHODS: A baseline and 2-year follow-up clinical and CSF study of 86 subjects, including 22 MCI patients that declined to AD (MCI-AD), 43 MCI that did not deteriorate (MCI-MCI) and 21 controls (NL-NL). All subjects were studied for total and phosphorylated tau (T-tau, P-tau(231)), amyloid beta (Abeta) Abeta(42)/Abeta(40) ratio, isoprostane (IP) as well as P-tau(231)/Abeta(42/40) and T-tau/Abeta(42/40) ratios. RESULTS: At baseline and at follow-up MCI-AD showed higher levels P-tau(231), T-tau, IP, P-tau(231)/Abeta(42/40) and T-tau/Abeta(42/40) ratios and lower Abeta(42)/Abeta(40) than MCI-MCI or NL-NL. Baseline P-tau(231) best predicted MCI-AD (80%, p<0.001) followed in accuracy by P-tau(231)/Abeta(42/40) and T-tau/Abeta(42/40) ratios (both 75%, p's<0.001), T-tau (74%, p<0.001), Abeta(42)/Abeta(40) (69%, p<0.01), and IP (68%, p<0.01). Only IP showed longitudinal effects (p<0.05). CONCLUSIONS: P-tau(231) is the strongest predictor of the decline from MCI to AD. IP levels uniquely show longitudinal progression effects. These results suggest the use of CSF biomarkers in secondary prevention trials.


Subject(s)
Alzheimer Disease/cerebrospinal fluid , Alzheimer Disease/diagnosis , Cognition Disorders/cerebrospinal fluid , Cognition Disorders/diagnosis , tau Proteins/cerebrospinal fluid , Aged , Aged, 80 and over , Amyloid beta-Peptides/analysis , Amyloid beta-Peptides/cerebrospinal fluid , Biomarkers/analysis , Biomarkers/cerebrospinal fluid , Cohort Studies , Disease Progression , Early Diagnosis , Female , Humans , Isoprostanes/analysis , Isoprostanes/cerebrospinal fluid , Longitudinal Studies , Male , Middle Aged , Peptide Fragments/analysis , Peptide Fragments/cerebrospinal fluid , Predictive Value of Tests , Prognosis , tau Proteins/analysis
7.
Neurobiol Aging ; 30(5): 672-81, 2009 May.
Article in English | MEDLINE | ID: mdl-17920160

ABSTRACT

While cerebrospinal fluid (CSF) biomarkers are of use in the prediction and diagnosis of Alzheimer's disease our understanding of the background effects of age and the ApoE genotype is limited. Seventy-eight community-based normal volunteers (mean age 60+/-10 years, range 36-86) were examined to determine the relationships between CSF measures of total tau (T-tau), hyperphosphorylated tau (P-tau 231), amyloid beta (Abeta42/Abeta40 ratio), and isoprostane (IP) with age and ApoE genotype. The results showed that age by epsilon4 genotype interactions were found for P-tau231 (beta=1.82; p<0.05) and IP (beta=1.6; p<0.05). T-tau CSF concentration increased with age. The increasing CSF concentrations of P-tau and IP in epsilon4 carriers suggest that early tauopathy and oxidative stress may be related to the increased risk for AD. The data also suggest that T-tau changes are more age dependent than Abeta changes. The evidence that P-tau231 and IP are the earliest markers for the neuronal damage related to AD awaits longitudinal study.


Subject(s)
Aging/genetics , Alzheimer Disease/cerebrospinal fluid , Alzheimer Disease/genetics , Apolipoproteins E/genetics , Genetic Predisposition to Disease/genetics , Adult , Aged , Aged, 80 and over , Aging/metabolism , Alzheimer Disease/diagnosis , Amyloid beta-Peptides/analysis , Amyloid beta-Peptides/cerebrospinal fluid , Apolipoprotein E4/genetics , Biomarkers/analysis , Biomarkers/cerebrospinal fluid , DNA Mutational Analysis , Dinoprost/analogs & derivatives , Dinoprost/analysis , Dinoprost/cerebrospinal fluid , Female , Gene Frequency/genetics , Genotype , Humans , Male , Middle Aged , Oxidative Stress/genetics , Peptide Fragments/analysis , Peptide Fragments/cerebrospinal fluid , Phosphorylation , Polymorphism, Genetic/genetics , tau Proteins/analysis , tau Proteins/cerebrospinal fluid
8.
Hum Brain Mapp ; 30(3): 874-82, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18381771

ABSTRACT

OBJECTIVES: Magnetic resonance (MRI) studies rely on sulcal boundaries to delineate the human entorhinal cortex (EC) and typically show that EC size is reduced in Alzheimer's disease (AD) and a predictor of future dementia. However, it is unknown if variations in the EC sulcal patterns are associated with AD. We classified the lateral EC sulcal boundary as either a rhinal or collateral pattern and tested the hypotheses that the rhinal pattern was (1) more common in AD and (2) associated with a smaller EC size. EXPERIMENTAL DESIGN: MRI was used to determine the prevalence of the rhinal and collateral EC patterns in 421 subjects (212 AD, 107 old normal (ONL), and 102 young NL (YNL). Anatomical validation studies of normal subjects were conducted at postmortem in 34 brain hemispheres and in vivo with 21 MRI volume studies. EC pattern reliability was studied with MRI in both cross-sectional and longitudinal designs. PRINCIPAL OBSERVATIONS: The rhinal pattern was more frequent in the right hemisphere in AD (47%) compared with ONL (28%, odds ratio = 2.25, P = 0.001). EC pattern was not related to ApoE genotype. The validations showed that the EC sulcal pattern was not associated with the neuronal number, surface area, or volume of the EC. In patients with antemortem MRI studied at postmortem it was equivalently determined, that EC patterns are reliably determined on MRI and do not change with the progressive atrophy of AD. CONCLUSIONS: The data indicate that the right hemisphere rhinal pattern is over represented in AD as compared with control. However, in normal subjects the EC rhinal pattern is not associated with a diminished EC tissue size. It remains to be demonstrated if the right EC rhinal sulcus pattern association with AD reflects genetic or developmental influences.


Subject(s)
Alzheimer Disease/pathology , Entorhinal Cortex/pathology , Adult , Aged , Aged, 80 and over , Female , Humans , Image Interpretation, Computer-Assisted , Magnetic Resonance Imaging , Male , Middle Aged
9.
Proc Natl Acad Sci U S A ; 104(48): 19067-72, 2007 Nov 27.
Article in English | MEDLINE | ID: mdl-18003925

ABSTRACT

Having a parent affected with late-onset Alzheimer's disease (AD) is a risk factor for developing AD among cognitively normal subjects. We examined whether cognitively normal subjects with a parental family history of AD show cerebral metabolic rate of glucose (CMRglc) reductions consistent with AD as compared with those without a family history and whether there are parent gender effects. Forty-nine 50- to 80-year-old normal subjects were examined who received clinical, neuropsychological, and 2-[(18)F]fluoro-2-deoxy-d-glucose-positron emission tomography examinations, including 16 subjects with a maternal (FHm) and eight with a paternal (FHp) family history of AD and 25 with no family history (FH(-)). FH groups were comparable for demographic and neuropsychological measures. As compared with both FH(-) and FHp groups, FHm subjects showed CMRglc reductions in the same regions as clinically affected AD patients, involving the posterior cingulate cortex/precuneus, parietotemporal and frontal cortices, and medial temporal lobes (P < 0.05, corrected for multiple comparisons). These effects remained significant after accounting for possible risk factors for AD, including age, gender, education, apolipoprotein E genotype, and subjective memory complaints. No CMRglc differences were found between FHp and FH(-) subjects. This study shows a relationship between reduced CMRglc in AD-vulnerable brain regions and a maternal family history of AD in cognitively normal individuals.


Subject(s)
Alzheimer Disease/genetics , Cerebral Cortex/metabolism , Genomic Imprinting , Glucose/metabolism , Positron-Emission Tomography , Aged , Aged, 80 and over , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/epidemiology , Alzheimer Disease/metabolism , Apolipoprotein E4/genetics , Brain Mapping , Cerebral Cortex/diagnostic imaging , Female , Fluorine Radioisotopes/pharmacokinetics , Fluorodeoxyglucose F18/pharmacokinetics , Genes, Mitochondrial , Genetic Heterogeneity , Genetic Predisposition to Disease , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Mothers , Retrospective Studies , Risk
SELECTION OF CITATIONS
SEARCH DETAIL
...